Urticaria Caused by Medication

What is Urticaria caused by medication?

Urticaria, commonly known as hives, is a skin reaction that appears as raised, red or flesh‑colored welts that itch, burn, or sting. When the reaction is triggered by a drug, it is called medication‑induced urticaria. The underlying mechanism is usually an allergic (IgE‑mediated) or non‑allergic (pseudo‑allergic) response that releases histamine and other chemicals from mast cells, leading to the characteristic wheals and surrounding edema.

Medication‑induced urticaria can develop within minutes to several days after taking a drug, and it may be isolated (only skin) or accompany systemic symptoms such as facial swelling, throat tightness, or gastrointestinal upset. While most cases are self‑limited, they can progress to a life‑threatening allergic reaction called anaphylaxis, which requires immediate emergency care.

Sources: Mayo Clinic; American Academy of Dermatology; NIH.

Common Causes

Many classes of medication have been implicated in causing urticaria. Below are the most frequently reported culprits:

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – ibuprofen, naproxen, aspirin.
• Antibiotics – especially penicillins, cephalosporins, sulfonamides, and fluoroquinolones.
• Opioids – morphine, codeine, tramadol.
• Anticonvulsants – carbamazepine, lamotrigine, phenytoin.
• Contrast media used in imaging studies (iodinated or gadolinium‑based).
• Biologic agents – monoclonal antibodies (e.g., rituximab, adalimumab).
• Vaccines – rare but reported after certain components or preservatives.
• Angiotensin‑converting enzyme (ACE) inhibitors – lisinopril, enalapril.
• Antifungal agents – terbinafine, ketoconazole.
• Herbal and over‑the‑counter supplements – especially those containing soy, pollen, or animal products.

In up to 40 % of acute urticaria cases, the exact drug trigger remains unidentified, underscoring the importance of a thorough medication history.

Associated Symptoms

Medication‑induced urticaria often appears with additional clinical features:

• Intense itching (pruritus) that may worsen at night.
• Swelling of the lips, eyelids, or hands (angio‑edema).
• Flushing or a generalized "warmth" sensation.
• Gastrointestinal symptoms – nausea, vomiting, abdominal cramps.
• Respiratory complaints – throat tightness, hoarseness, wheezing (suggestive of progressing anaphylaxis).
• Fever or malaise, especially when the reaction is part of a drug hypersensitivity syndrome.

When symptoms are confined to the skin and resolve within 24 hours, the condition is usually classified as acute urticaria. Persistent lesions beyond six weeks indicate chronic urticaria, which may still be drug‑related but often requires a broader work‑up.

When to See a Doctor

Prompt medical evaluation is advisable in the following scenarios:

• Urticaria appears for the first time after starting a new medication.
• Welts last longer than 24 hours or recur daily.
• Swelling involves the face, lips, tongue, or throat.
• Difficulty breathing, wheezing, or a feeling of “tightness” in the chest.
• Accompanying gastrointestinal symptoms (vomiting, diarrhea) that are severe.
• Fainting, dizziness, or a rapid heartbeat.
• You are pregnant, breastfeeding, or have a chronic medical condition (e.g., asthma, heart disease).

If any of the above are present, seek care immediately—especially the airway‑related signs.

Diagnosis

Diagnosing medication‑induced urticaria relies on a combination of clinical assessment and targeted testing.

1. Detailed History

• Exact timing of the rash relative to drug ingestion.
• All prescription, over‑the‑counter, herb, and supplement use in the past 4 weeks.
• Previous allergic reactions or known drug sensitivities.
• Family history of atopy (eczema, asthma, allergic rhinitis).

2. Physical Examination

• Inspection of the skin for wheal size, distribution, and presence of angio‑edema.
• Assessment of airway, cardiovascular status, and any systemic involvement.

3. Laboratory & Allergy Testing

• Complete blood count (CBC) – may show eosinophilia if an allergic mechanism is present.
• Serum tryptase – elevated levels shortly after symptom onset suggest mast‑cell activation.
• Skin prick or intradermal testing for specific drugs (performed by an allergist).
• Blood specific IgE testing for certain antibiotics or analgesics.
• In chronic or severe cases, a drug provocation test under controlled conditions may be required.

4. Exclusion of Other Causes

Since infections, autoimmune diseases, and physical triggers can mimic drug‑induced urticaria, clinicians will rule these out as needed.

Treatment Options

Treatment aims to stop the allergic cascade, relieve symptoms, and prevent recurrence.

1. Immediate Management

• Discontinue the suspected drug as soon as possible.
• Antihistamines – second‑generation agents (cetirizine, loratadine, fexofenadine) are first‑line due to fewer drowsiness effects. For severe itching, diphenhydramine (first‑generation) can be used short‑term.
• H2‑blockers (e.g., ranitidine or famotidine) added to H1‑antihistamines may improve control in refractory cases.
• Corticosteroids – oral prednisone 0.5 mg/kg for 5‑7 days may be prescribed for persistent or extensive rash.
• Cold compresses and soothing lotions (calamine, colloidal oatmeal) for symptomatic relief.

2. Management of Angio‑edema or Anaphylaxis

• Intramuscular epinephrine (0.3 mg autoinjector) is the first‑line treatment for anaphylaxis.
• Follow with emergency medical services, supplemental oxygen, IV fluids, and possibly antihistamines and steroids.

3. Chronic or Refractory Cases

• Higher‑dose antihistamines (up to four times standard dose) under physician guidance.
• Omalizumab (anti‑IgE monoclonal antibody) – FDA‑approved for chronic spontaneous urticaria and increasingly used when drug‑induced urticaria persists after avoidance.
• Ciclosporin or other immunosuppressants in select patients, typically under dermatology supervision.

4. Patient Education

• Provide written information on the identified culprit drug and alternatives.
• Teach patients how to use an epinephrine autoinjector if they have experienced systemic symptoms.
• Encourage keeping an allergy diary for future medication exposures.

Prevention Tips

While not every drug reaction can be predicted, these strategies reduce risk:

• Review medication lists with your healthcare provider before starting new prescriptions.
• Ask about cross‑reactivity (e.g., penicillin allergy may extend to certain cephalosporins).
• Carry an up‑to‑date allergy card or bracelet indicating known drug allergies.
• For known NSAID‑sensitive individuals, consider using acetaminophen (paracetamol) as an alternative, under physician advice.
• When possible, use the lowest effective dose and the shortest treatment duration.
• Inform pharmacists of any previous drug reactions—they can flag potential problems.
• In patients with a history of severe reactions, consider pre‑medication with antihistamines before unavoidable exposures (e.g., contrast studies).
• Maintain a **medication diary** documenting start dates, doses, and any adverse skin changes.

Emergency Warning Signs

Key Take‑aways

• Medication‑induced urticaria is a common, often allergic skin reaction that can range from mild itching to severe anaphylaxis.
• Promptly discontinuing the suspected drug and using antihistamines are the first steps in management.
• Seek urgent medical care for airway involvement, rapid spreading rash, or systemic symptoms.
• Accurate drug histories, allergy testing, and patient education are essential to prevent recurrence.

References:

1. Mayo Clinic. “Urticaria (hives).” Accessed May 2024. https://www.mayoclinic.org/diseases-conditions/hives/symptoms-causes/syc-20354973
2. American Academy of Dermatology. “Urticaria (Hives).” 2023. https://www.aad.org/public/diseases/a-z/urticaria
3. National Institutes of Health. “Drug Allergy.” 2022. https://www.niaid.nih.gov/diseases-conditions/drug-allergy
4. Cleveland Clinic. “Urticaria (Hives) Treatment.” 2023. https://my.clevelandclinic.org/health/diseases/12639-hives-urticaria
5. World Health Organization. “Anaphylaxis.” 2021. https://www.who.int/news-room/fact-sheets/detail/anaphylaxis